SCHEMBL6513754

SCHEMBL6513754

COC(=O)[C@H](CC(C)C)Nc1cc(Nc2cccc(F)c2)cc(Sc2ccc(OC)cc2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CTSK P43235 4/20 0.39
MAPT P10636 3/20 0.36
TAS1R3 Q7RTX0 3/20 0.36
TAS1R1 Q7RTX1 3/20 0.36
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
FPR2 P25090 1/20 0.36
SCN9A Q15858 1/20 0.36
POLB P06746 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
MAPK1 P28482 1/20 0.35
HTT P42858 1/20 0.35
PTGDR Q13258 1/20 0.35
CTSL P07711 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6513761 1.00 ALDH1A1 (0.39) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6513221 0.93 CTSK (0.40) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6513215 0.93 CTSK (0.40) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL8299305 0.91 CTSK (0.38) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6510466 0.90 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6510461 0.90 ALDH1A1 (0.40) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6512111 0.87 CTSK (0.38) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6512117 0.87 CTSK (0.38) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6517007 0.87 CA12 (0.41) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6510002 0.87 CTSK (0.43) ALDH1A1CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed
WO-2005003103-A2 2, 4, 6-TRI-SUBSTITUTED 6-MEMBERED HETEROCYCLES AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES ASTRAZENECA AB (SE) 2005-01-13 WO disclosed